VIRTUS LIFESCI BIOTECH CLINICAL TRIALS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.63 USD | +1.80% |
|
-2.87% | +4.90% |
| Current month | -12.02% | ||
| 1 month | -10.84% |
Investment objective
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 39.43 USD | +0.77% | -7.38% | +156.37% | 2.25% | ||
| 65.57 USD | -1.09% | -4.97% | -21.46% | 1.54% | ||
| 11.85 USD | +4.68% | -0.59% | +45.76% | 1.53% | ||
| 7.73 USD | +14.52% | -15.98% | -6.98% | 1.52% | ||
| 8.095 USD | +2.08% | -3.75% | +98.41% | 1.51% | ||
| 16.64 USD | +6.49% | -3.90% | +63.35% | 1.50% | ||
| 25.46 USD | +2.37% | +3.37% | +91.43% | 1.45% | ||
| 64.93 USD | +1.69% | -4.44% | +248.90% | 1.43% | ||
| 12.95 USD | -1.75% | -4.64% | +7.65% | 1.43% | ||
| 55.24 USD | -0.97% | -4.76% | +38.93% | 1.39% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-23 | 25.63 | +1.80% | 229 |
| 24-04-22 | 25.17 | +1.19% | 802 |
| 24-04-19 | 24.88 | -1.96% | 2,095 |
| 24-04-18 | 25.38 | -1.42% | 233 |
| 24-04-17 | 25.74 | -1.26% | 1,431 |
Other stock markets
Delayed Quote Nyse
Last update April 23, 2024 at 04:10 pm EDT
More quotesETF Ratings
 |
Description
| US26923G3011 | |
|---|---|
| Total Expense Ratio | 0.79% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | LifeSci Biotechnology Clinical Trials Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2014-12-15
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2024-03-26 )
| AuM (EUR) | 11 M€ |
|---|---|
| AuM 1M | 12 M€ |
| AuM 3 months | 10 M€ |
| AuM 6 months | 8 M€ |
| AuM 12 months | 11 M€ |
- Stock Market
- ETF
- BBC ETF
